$中国抗体-B(03681)$ SinoMab BioSci_老虎社区_美港股上老虎

稍微放量
04-01

$中国抗体-B(03681)$ SinoMab BioScience (HKG:3681) dosed the first patient in a phase 2 clinical trial of SM17 in China, according to a Wednesday Hong Kong bourse filing.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":548991298857112,"tweetId":"548991298857112","gmtCreate":1775052987063,"gmtModify":1775052989474,"author":{"id":4108559598165560,"idStr":"4108559598165560","authorId":4108559598165560,"authorIdStr":"4108559598165560","name":"稍微放量","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/03681\">$中国抗体-B(03681)$ </a> SinoMab BioScience (HKG:3681) dosed the first patient in a phase 2 clinical trial of SM17 in China, according to a Wednesday Hong Kong bourse filing.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/03681\">$中国抗体-B(03681)$ </a> SinoMab BioScience (HKG:3681) dosed the first patient in a phase 2 clinical trial of SM17 in China, according to a Wednesday Hong Kong bourse filing.</p></body></html>","text":"$中国抗体-B(03681)$ SinoMab BioScience (HKG:3681) dosed the first patient in a phase 2 clinical trial of SM17 in China, according to a Wednesday Hong Kong bourse filing.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/548991298857112","repostId":0,"isVote":1,"tweetType":1,"viewCount":150,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["03681"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":144,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}